I have an appointment on Friday at a hospital that's doing a clinical trial with Schering 503034, a protease inhibitor along the lines of vx-950. All the arms of the study will receive peg and riba with varying dosages and durations of the new drug (including one arm with placebo).
Does anyone on this board know anything about this drug?
Does it look as promising as vx-950 or is it too early to say?
Also, can anyone suggest what questions I need to ask at the screening appointment?
I'm not necessarily in a hurry to do treatment. Although I think I've had hep c for 30 years, my recent biopsy was stage 1, grade 2 and VL 800,000. But if this is a good opportunity I'm willing to give it a shot. Any thoughts? Thanks for anything you can suggest.